These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2839996)

  • 1. Central interactions between aldosterone and vasopressin on cardiovascular system.
    Janiak P; Brody MJ
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R166-73. PubMed ID: 2839996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
    Huang BS; White RA; Ahmad M; Leenen FH
    Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.
    Webb RL; Osborn JW; Cowley AW
    Am J Physiol; 1986 Dec; 251(6 Pt 2):H1244-51. PubMed ID: 3789178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: relevance to stress and interaction with vasopressin.
    Cudnoch-Jedrzejewska A; Szczepanska-Sadowska E; Dobruch J; Puchalska L; Ufnal M; Kowalewski S; Wsół A
    Stress; 2008 Jul; 11(4):290-301. PubMed ID: 18574789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the central vasopressin system: a common pathway for several centrally acting pressor agents.
    Gruber KA; Eskridge SL
    Am J Physiol; 1986 Sep; 251(3 Pt 2):R476-80. PubMed ID: 3752282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II.
    Loń S; Szczepańska-Sadowska E; Szczypaczewska M
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H167-73. PubMed ID: 8769748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin mechanism-mediated pressor responses caused by central angiotensin II in the ovine fetus.
    Shi L; Guerra C; Yao J; Xu Z
    Pediatr Res; 2004 Nov; 56(5):756-62. PubMed ID: 15347766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
    Ishikawa S; Schrier RW
    Am J Physiol; 1984 Jan; 246(1 Pt 2):H104-13. PubMed ID: 6364835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of endogenous vasopressin in the hypertensive and bradycardic response to central alpha 1-adrenergic stimulation.
    Hiwatari M; Johnston CI
    Clin Exp Pharmacol Physiol; 1985; 12(3):221-5. PubMed ID: 2863022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrally regulated blood pressure response to vasoactive peptides is modulated by corticosterone.
    van Acker SA; Oitzl MS; Fluttert MF; de Kloet ER
    J Neuroendocrinol; 2002 Jan; 14(1):56-63. PubMed ID: 11903813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of vasopressin on angiotensin and norepinephrine pressor action in rats.
    Elijovich F; Barry CR; Krakoff LR; Kirchberger M
    Am J Physiol; 1984 Dec; 247(6 Pt 2):H973-7. PubMed ID: 6507644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
    Feuerstein G; Zerbe RL; Faden AI
    J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation for roles of brain prostaglandins in the catecholamine-induced vasopressin secretion in conscious rats.
    Yamaguchi K; Hama H
    Brain Res; 1993 Apr; 607(1-2):149-53. PubMed ID: 8386972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A; Leenen FH
    Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.